AnaptysBio Inc at Bank of America Merrill Lynch Health Care Conference Transcript
Thank you so much for attending the Bank of America Health Care Conference at Vegas. My name is Ching Wong, and I am an equity analyst from the large-cap biotech team. And today, it's my pleasure to host CEO of AnaptysBio, Hamza Suria. And in the next like maybe 20, 25 minutes, he will give us a presentation about the company and the program update, and we might have a few minutes for follow-up Q&As. Welcome.
Thank you, Ching, for the introduction and thank you to BAML for having us here. My name is Hamza Suria. I'm President and CEO of AnaptysBio. I'll be providing a brief update regarding our progress and upcoming milestones.
As shown on Slide 2, I will be making forward-looking statements during the course of my presentation. Please review our SEC filings for relevant risks and some additional considerations.
AnaptysBio is a clinical stage antibody development company. We're focused on first-in-class opportunities in the inflammatory diseases, and we have an
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |